← FDA Drug Approvals (Drugs@FDA)

ANDA205752

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SPECTRUM PHARMS · Approved 2017-12-07

Drug application

FDA Application #

ANDA205752

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

SPECTRUM PHARMS

First approval

2017-12-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown